The partnership saw Philidor aggressively market Valeant's more expensive drugs over cheaper generics preferred by insurers, which caught the attention of US lawmakers and investigators now looking into its pricing. Earlier this month, Valeant announced a drug distribution deal with pharmacy giant Walgreens that will lower prices of many medications by 10 per cent in the United States. The deal applies to Valeant's branded dermatology and ophthalmology prescription drugs, including the high-selling Jublia treatment for toe fungus. AFP